Alvotech's (NASDAQ:ALVO) biggest owners are private equity firms who got richer after stock soared 19% last week

In This Article:

Key Insights

  • The considerable ownership by private equity firms in Alvotech indicates that they collectively have a greater say in management and business strategy

  • 63% of the business is held by the top 2 shareholders

  • Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a company

A look at the shareholders of Alvotech (NASDAQ:ALVO) can tell us which group is most powerful. With 34% stake, private equity firms possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

As a result, private equity firms collectively scored the highest last week as the company hit US$3.6b market cap following a 19% gain in the stock.

Let's take a closer look to see what the different types of shareholders can tell us about Alvotech.

View our latest analysis for Alvotech

ownership-breakdown

What Does The Institutional Ownership Tell Us About Alvotech?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

We can see that Alvotech does have institutional investors; and they hold a good portion of the company's stock. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Alvotech, (below). Of course, keep in mind that there are other factors to consider, too.

earnings-and-revenue-growth

We note that hedge funds don't have a meaningful investment in Alvotech. Aztiq Pharma Partners S.à R.L. is currently the largest shareholder, with 34% of shares outstanding. Celtic Holdings S.C.A. is the second largest shareholder owning 30% of common stock, and The Vanguard Group, Inc. holds about 1.0% of the company stock.

After doing some more digging, we found that the top 2 shareholders collectively control more than half of the company's shares, implying that they have considerable power to influence the company's decisions.

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.